"Halothane". NIOSH Pocket Guide to Chemical Hazards. (NIOSH) National Institute for Occupational Safety and Health, Centers for Disease Control. Archived from the original on 8 December 2015. Retrieved 3 November 2015.
World Health Organization (2025). The selection and use of essential medicines 2025: report of the 25th WHO Expert Committee on Selection and Use of Essential Medicines: executive summary. Geneva: World Health Organization. doi:10.2471/B09544. hdl:10665/382350.
Hankins DC, Kharasch ED (9 May 1997). "Determination of the halothane metabolites trifluoroacetic acid and bromide in plasma and urine by ion chromatography". Journal of Chromatography B: Biomedical Sciences and Applications. 692 (2): 413–8. doi:10.1016/S0378-4347(96)00527-0. ISSN0378-4347. PMID9188831.
Sakai EM, Connolly LA, Klauck JA (December 2005). "Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane". Pharmacotherapy. 25 (12): 1773–88. doi:10.1592/phco.2005.25.12.1773. PMID16305297. S2CID40873242.
Patel SS, Goa KL (April 1996). "Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia". Drugs. 51 (4): 658–700. doi:10.2165/00003495-199651040-00009. PMID8706599. S2CID265731583.
Mueller LM (March 2021). "Medicating Anaesthesiology: Pharmaceutical Change, Specialisation and Healthcare Reform in Post-War Britain". Social History of Medicine. 34 (4): 1343–65. doi:10.1093/shm/hkaa101.
Himmel HM (2008). "Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons?". Critical Reviews in Toxicology. 38 (9): 773–803. doi:10.1080/10408440802237664. PMID18941968. S2CID12906139.
Chavez CA, Ski CF, Thompson DR (July 2014). "Psychometric properties of the Cardiac Depression Scale: a systematic review". Heart, Lung & Circulation. 23 (7): 610–8. doi:10.1016/j.hlc.2014.02.020. PMID24709392.
Gelb AW, Vreede E (October 2024). "Availability of halothane is still important in some parts of the world". Canadian Journal of Anaesthesia. 71 (10): 1427–1428. doi:10.1007/s12630-024-02836-9. PMID39256303.
World Health Organization (2025). The selection and use of essential medicines 2025: report of the 25th WHO Expert Committee on Selection and Use of Essential Medicines: executive summary. Geneva: World Health Organization. doi:10.2471/B09544. hdl:10665/382350.
Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM (January 2018). Halothane. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. PMID31643481. NBK548151.
Gyorfi MJ, Kim PY (2022). Halothane Toxicity. StatPearls. Treasure Island (FL): StatPearls Publishing. PMID31424865. NBK545281.
Hankins DC, Kharasch ED (9 May 1997). "Determination of the halothane metabolites trifluoroacetic acid and bromide in plasma and urine by ion chromatography". Journal of Chromatography B: Biomedical Sciences and Applications. 692 (2): 413–8. doi:10.1016/S0378-4347(96)00527-0. ISSN0378-4347. PMID9188831.
Sakai EM, Connolly LA, Klauck JA (December 2005). "Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane". Pharmacotherapy. 25 (12): 1773–88. doi:10.1592/phco.2005.25.12.1773. PMID16305297. S2CID40873242.
Patel SS, Goa KL (April 1996). "Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia". Drugs. 51 (4): 658–700. doi:10.2165/00003495-199651040-00009. PMID8706599. S2CID265731583.
Halogenated Anesthetics. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. January 2018. PMID31644158. NBK548851.
Ma TG, Ling YH, McClure GD, Tseng MT (October 1990). "Effects of trifluoroacetic acid, a halothane metabolite, on C6 glioma cells". Journal of Toxicology and Environmental Health. 31 (2): 147–158. Bibcode:1990JTEH...31..147M. doi:10.1080/15287399009531444. PMID2213926.
Himmel HM (2008). "Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons?". Critical Reviews in Toxicology. 38 (9): 773–803. doi:10.1080/10408440802237664. PMID18941968. S2CID12906139.
Chavez CA, Ski CF, Thompson DR (July 2014). "Psychometric properties of the Cardiac Depression Scale: a systematic review". Heart, Lung & Circulation. 23 (7): 610–8. doi:10.1016/j.hlc.2014.02.020. PMID24709392.
Gelb AW, Vreede E (October 2024). "Availability of halothane is still important in some parts of the world". Canadian Journal of Anaesthesia. 71 (10): 1427–1428. doi:10.1007/s12630-024-02836-9. PMID39256303.
Miller AL, Theodore D, Widrich J (2022). Inhalational Anesthetic. StatPearls. Treasure Island (FL): StatPearls Publishing. PMID32119427. NBK554540.
Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM (January 2018). Halothane. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. PMID31643481. NBK548151.
Gyorfi MJ, Kim PY (2022). Halothane Toxicity. StatPearls. Treasure Island (FL): StatPearls Publishing. PMID31424865. NBK545281.
USgranted 2921098,Suckling CW, Raventos J,"Process for the Preparation of 1,1,1-Trifluoro-2-Bromo-2-Chloroethane",published 30 June 1958,issued 12 January 1960, assigned to Imperial Chemical Industries
Sakai EM, Connolly LA, Klauck JA (December 2005). "Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane". Pharmacotherapy. 25 (12): 1773–88. doi:10.1592/phco.2005.25.12.1773. PMID16305297. S2CID40873242.
Patel SS, Goa KL (April 1996). "Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia". Drugs. 51 (4): 658–700. doi:10.2165/00003495-199651040-00009. PMID8706599. S2CID265731583.
Himmel HM (2008). "Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons?". Critical Reviews in Toxicology. 38 (9): 773–803. doi:10.1080/10408440802237664. PMID18941968. S2CID12906139.
"Halothane". Anesthesia General. 31 October 2010. Archived from the original on 16 February 2011.
"Halothane". NIOSH Pocket Guide to Chemical Hazards. (NIOSH) National Institute for Occupational Safety and Health, Centers for Disease Control. Archived from the original on 8 December 2015. Retrieved 3 November 2015.
Hankins DC, Kharasch ED (9 May 1997). "Determination of the halothane metabolites trifluoroacetic acid and bromide in plasma and urine by ion chromatography". Journal of Chromatography B: Biomedical Sciences and Applications. 692 (2): 413–8. doi:10.1016/S0378-4347(96)00527-0. ISSN0378-4347. PMID9188831.